Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement

Breakthrough invasive fungal infections (bIFI) cause significant morbidity and mortality. Their diagnosis can be challenging due to reduced sensitivity to conventional culture techniques, serologic tests, and PCR-based assays in patients undergoing antifungal therapy, and their diagnosis can be dela...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Jeffrey D. Jenks, Jean-Pierre Gangneux, Ilan S. Schwartz, Ana Alastruey-Izquierdo, Katrien Lagrou, George R. Thompson III, Cornelia Lass-Flörl, Martin Hoenigl, European Confederation of Medical Mycology (ECMM) Council Investigators
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI AG 2020-10-01
Cyfres:Journal of Fungi
Pynciau:
breakthrough invasive fungal infections
invasive candidiasis
invasive mold infections
endemic mycoses
diagnostics
Mynediad Ar-lein:https://www.mdpi.com/2309-608X/6/4/216
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg